Yonsei University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Evaluation of Efficacy, Quality of Life and Cost Effectiveness of Short-course Radiotherapy Followed by Capecitabine Plus Oxaliplatin chemotheRapy and TME for High-risk Rectal Cancer (ESCORT Trial)
Not Applicable
- Conditions
- Locally Advanced Rectal Cancer
- Interventions
- Radiation: preoperative short-course radiotherapy
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 31
- Registration Number
- NCT03676517
- Locations
- 🇰🇷
The Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of
Developing of Virtual Reality Based Neurologic Examination Teaching Tool(VRNET)
Not Applicable
Completed
- Conditions
- Medical Students
- Interventions
- Other: Standard patients with VRNETOther: standard patients
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 95
- Registration Number
- NCT03653221
- Locations
- 🇰🇷
Department of emergency medicine, Yonsei University College of Medicine, Seoul, Korea, Seoul, Korea, Republic of
Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol
Not Applicable
Completed
- Conditions
- Blood Cholesterol
- Interventions
- Dietary Supplement: unripe Bokbunja ExtractDietary Supplement: Placebo
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 80
- Registration Number
- NCT03649620
A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT
Not Applicable
Completed
- Conditions
- Impaired Glucose ToleranceImpaired Fasting GlucoseNormal
- Interventions
- Dietary Supplement: Chitosan Oligosaccharide (GO2KA1)Dietary Supplement: White egg
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 37
- Registration Number
- NCT03650023
- Locations
- 🇰🇷
Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University., Seoul, Korea, Republic of
The Effects of Jeju Steaming Onion(Oniro) on Reducing Body Fat of Overweight or Obesity Subjects
Not Applicable
Completed
- Conditions
- ObesityOverweightDiabetes Mellitus
- Interventions
- Dietary Supplement: jeju steam onionDietary Supplement: baked barley powder
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 56
- Registration Number
- NCT03645382
- Locations
- 🇰🇷
Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University., Seoul, Korea, Republic of
Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Non-alcoholic Fatty Liver Disease in Type 2 Diabetic Patients With Fatty Liver
Phase 4
Completed
- Conditions
- MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System DiseaseLiver DiseasesFatty LiverMetabolic Dysfunction-Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHypoglycemic AgentsPhysiological Effects of DrugsSodium-Glucose Cotransporter 2 Inhibitors
- Interventions
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 60
- Registration Number
- NCT03646292
- Locations
- 🇰🇷
Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea, Seoul, Korea, Republic of
A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer
Phase 2
- Conditions
- Unresectable Metastatic Right-sided Colon Cancer Starting First-line Combination ChemotherapyUnresectable Metastatic Right-sided Colon Cancer, Stage IV
- Interventions
- Drug: A-FOLFOXIRIDrug: Arm II (A-FOLFOX/A-FOLFIRI)
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 120
- Registration Number
- NCT03641976
- Locations
- 🇰🇷
Yonsei Cancer Center, Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery
Not Applicable
Completed
- Conditions
- Dry EyeCataract Surgery
- Interventions
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 150
- Registration Number
- NCT03640351
- Locations
- 🇰🇷
Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul, Korea, Republic of
n-3 Fatty Acids in Enteral Formula on NK Cell Activity
Not Applicable
Completed
- Conditions
- Enteral Nutrition
- Interventions
- Dietary Supplement: vegetable (canola, flaxseed) derived n-3 fatty acidDietary Supplement: soybean oil
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 94
- Registration Number
- NCT03638661
Predictability of Preoperative Carotid Artery Corrected Flow Time for Hypotension After Spinal Anesthesia in Patients Undergoing Cesarean Section
Completed
- Conditions
- Cesarean Section
- Interventions
- Diagnostic Test: Doppler sonographic measurement
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 38
- Registration Number
- NCT03631329
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath